Search

everythinglearnresearchcommunity

for

Search:↓

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Divalproex sodium significantly improved headaches in two-thirds of patients.

TRPV3 is important for skin health and could be a target for treating skin diseases.

Rapamycin treatment helps reduce brain inflammation and symptoms of mitochondrial disease by blocking specific pathways in mice.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

Progesterone and its byproducts control a specific receptor in the brain independently of progesterone receptors, affecting conditions related to the menstrual cycle.

Two new compounds were found that could promote hair growth as well or better than minoxidil.

The combination therapy significantly improved Riehl’s melanosis in patients without serious side effects.

Minoxidil protects heart and improves recovery.

Higher levels of certain nerve-related proteins are linked to hair loss in women with scalp pain.

PM-9 and finasteride effectively inhibit the enzyme that converts testosterone to DHT.

Notopterygii rhizoma et radix (Qiang Huo) can effectively treat psoriasis by reducing skin symptoms and inflammation.

RORA may help regulate hair growth by affecting hair follicle stem cells.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Finasteride reduces movement issues in Parkinson's disease rats.

Loss of Dnmt3a and Dnmt3b increases aggressive skin tumors by affecting PPAR-γ.

Peptide nanoparticles can effectively deliver CRISPR-Cas9 to target KRAS mutations in cancer.

Cepharanthine may help treat COVID-19 by targeting multiple pathways.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

Certain defective glucocorticoid receptor mutants move faster inside cell nuclei and work less effectively.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Ivarmacitinib effectively regrows hair in severe alopecia areata.

Estradiol stops hair growth in mice, but an antagonist can reverse this effect.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.